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Living With and Treating Rare Diseases: Experiences of Patients and Professional 
Health Care Providers  
Lorenza Garrino1 , Elisa Picco2 , Ivana Finiguerra3 , Daniela Rossi1,3, Paola Simone3 , and Dario Roccatello1 
Abstract 
We explored the experiences of illness of patients suffering from rare diseases and of the health 
professionals who care for them at the Center for the Interregional Coordination of Rare Diseases of 
Piedmont and Valle d’Aosta in Italy. The research was carried out between 2010 and 2011. We collected 
qualitative data from 22 patients and 12 health professional health care providers. The interviews were 
analyzed using the Colaizzi phenomenological approach. We identified five themes from the narratives of 
the patient participants—dealing with disease development, living with the disease, everyday living, 
relating to others, and relations with health care providers—and four themes from the professional health 
care participants—dealing with the disease, dealing with expectations, building relationships, and being 
operators in the context. The study has raised awareness about the issue of rare diseases and it provides 
some useful considerations for improving services.  
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Rare diseases cover a heterogeneous set of pathologies that can strike any organ or system of the human 
body. In literature, there are different definitions: the European Union defines as a rare disease a pathology 
that affects five or fewer individuals out of 10,000 in the European population; instead, in the United States 
a rare disease is one that affects less than 200,000 individuals in all the nation (Wästfelt, Fadeel, & Henter, 
2006). 
From the existing estimates, the number of disorders in the category of rare disease is very high (> 5,000 
according to the WHO). These are diseases that can strike between 6% and 8% of the population in their 
lives. Thus, even though the prevalence of these pathologies is low, the total number of people affected is 
about 30 million in the European Union and about 25 million in the United States (Agazio et al., 2005; 
Schieppati, Henter, Daina, & Aperia, 2008). Most of these disorders have a genetic origin, while the rare 
diseases whose origin is not genetic can instead be the result of a bacterial or viral infection, or it may 
depend on environmental causes, allergy, or have a proliferative basis (Faurisson & Kole, 2009). Despite the 
high number of pathologies covered by the definition, it is possible to identify some common features: 
They are diseases of a chronic, degenerative nature; they may involve severe disability and heavily 
compromise the quality of life. Such diseases require continuous specialist assistance. Patients with rare 
diseases have common experiences as regards delays in diagnosis, difficulties in access to treatment and 
care, and the loss of economic and social opportunities. Because of the very small numbers of cases and 
their dispersion, scientific research has shown little interest in these pathologies owing to the difficulties 
involved in organizing clinical studies for identifying their causes and studying their development, and in 
amortizing the costs of a specific pharmacological study. Europe has tried to protect the rights of these 
patients by issuing regulations and recommendations. The Member States have been invited to draw up 
and put into effect appropriate strategies and measures to guarantee patients access to high-quality health 
care, including diagnostic tools and treatment, and to promote and foster research in this field. Moreover, 
the European Union has promoted in each nation the identification of Centers of competence for rare 
diseases that participate in the European networks of reference (European Parliament and the Council of 
the European Union, 2000; Council of the European Union, 2009). In Italy, the national network of rare 
diseases was established by Decree n. 279/2001 (Italian Ministry of Health, 2001). This is a clinical and 
epidemiological network composed of accredited Centers for the prevention, surveillance, diagnosis, and 
treatment of rare diseases that are specifically identified by the regional health authorities. The aims of the 
network are to promote the spreading of information and documentation on rare diseases, facilitate access 
to specialist care for patients, and provide consultancy and support to the doctors of the Italian Health 
Service (Decree n.279/2001). 
People who may have a rare disease go to these Centers to find a diagnosis and appropriate treatment. As 
these pathologies are by nature chronic, potentially invalidating, with a clinical course that alternates 
between periods of acute flares and phases when the disease is in remission, patients are followed for a 
very long time, also for the duration of their lives, coming into contact with various types of professional 
health care providers who accompany them in their treatment program. The medical treatment currently 
available for these patients is unlikely to clear up the disease. These conditions can create an experience of 
suffering in patients undergoing treatment, heightening the feelings of isolation that they already have on 
account of the rare nature of their condition, and they can give rise to a profound sense of impotence in 
the professional health care providers. There is therefore the need to build a meaningful relationship 
between the person with the rare disease and the health care staff. 
All these considerations led us to set up a research project in one of the Regional Centers of Reference for 
Rare Diseases. To raise awareness of the experiences of patients and professional health care providers can 
be a useful strategy for identifying elements for improving the quality of the health services provided 
(Knight & Senior, 2006). 
The theoretical framework of the project is provided by narrative medicine (Charon, 2001, 2004, 2006; 
Greenhalgh & Hurwitz, 1998). Acting as a bridge between the clinical knowledge of the physician and that 
of other professional health care providers and the patients’ subjective experiences, narrative medicine 
aims to “accompany” the various stakeholders toward the shared management of the disease. This 
approach assumes that the narration constitutes the ordering element of the experience and allows the 
structuring of the continuity of subjective experience. 
We realized our study using narrative medicine as a tool for improving the quality of care through the 
analysis of the narratives of the patient participants and professional health care provider participants, 
restructuring them in a shared interpretative framework. The aim of this study has been both to explore 
the impact of the rare disease on the patients’ lives and together with the experience of the health 
professionals who look after these patients on a daily basis, and also to highlight the positive and the 
critical aspects of the health care services. 
Method 
Participants 
We carried out the study in a Regional Center of Reference for Rare Diseases (CMID; Multidisciplinary 
Center of Immunopatology and Documentation of Rare Diseases). It supports a model based on the 
promotion of generally agreed diagnostic and treatment health care protocols, on the swift diffusion of 
information on health and legislation and on the use of the Interregional Register of Rare Diseases as a tool 
for identifying problems such as delayed diagnosis, inappropriate treatment approaches, and the areas 
where it is necessary to invest greater resources. The Center is composed of an outpatients department 
where new patients are examined and regular patients have their routine check-up, and a day hospital for 
those who need infusion therapy or invasive treatment as they are in an acute phase of the disease. 
The activity of the Center is based on multiple interdisciplinary cooperation among specialists 
(immunologists, clinical pathologists, hematologists, nephrologists, rheumatologists, infectious disease 
specialists, geneticists) and various professional health care providers (doctors, nurses, physiotherapists, 
laboratory technicians, health and social workers). 
We have chosen purposive sampling by asking a group of patients and professional health care providers at 
the Center to participate. In the study, there are patients with rare diseases according to the European 
Union definition of the year 2000: diseases with prevalence equal or inferior to 5 cases per 10,000 people in 
the EU. Patients participating in the study have to have been registered for at least one session in the day 
hospital and are still undergoing active follow-up, whereas the professional health care provider 
participants (doctors, nurses, health and social workers) must have worked at the Center for at least 6 
months. The number of patient participants involved was established on the basis of reaching data 
saturation (Speziale & Carpenter, 2011). All of the professional health care providers at the Center were 
invited to participate. The Directorate-General of the Local Health Authority, to which the Center refers, 
and the Directorate of the Hospital Unit and the Director of the Department of the Center were all 
informed about the type of study, and consent was granted. The Institutional Review Board approved the 
study design and methods. Participation in the study was voluntary. Those contacted were informed about 
the aims of the study and the means of data collection. We pointed out the need to record the interviews. 
Participants were guaranteed anonymity and gave their written consent. 
We interviewed 22 patients with different diagnoses of rare diseases (such as Scleroderma, Horton’s 
disease, Wegener’s granulomatosis, Mixed connective tissue disease, Addison’s disease, Behcet’s disease, 
Gaucher’s disease) and 12 professional health care providers including health and social workers, nurses, 
doctors, and junior specialist physicians (see Table 1). 
Procedures 
Narrative inquiry, which is a form of qualitative research that uses the collection of stories as its source of 
data, was adopted (Duffy, 2007). We used autobiographical narrative interviews to learn about the patient 
participants’ and professional health care provider participants’ experiences, according to the narrative 
inquiry approach. In this way, it was possible to show the voice of each participant and provide the 
opportunity to understand the complexity and depth of the phenomenon studied, revealing the 
interviewees’ experiences, perceptions, and thoughts in their own words (Dicicco-Bloom & Crabtree, 2006; 
Giarelli, 2005). 
The research team drew up two interview outlines, one for the patient participants and the other for the 
professional health care provider participants, with cues able to stimulate conversation and considerations 
with the interviewees, helping them to reconstruct their experience of the disease or of dealing with it: 
The experience of living with a rare disease: 
experience of first symptoms, 
access to the health care and social services: asking for help, 
experience of the time up to diagnosis (undergoing diagnostic tests, waiting, errors in diagnosis), 
getting a diagnosis: impact on personal life, 
finding the Rare Diseases Center, 
receiving treatment/support (over time . . . , drugs, psychological support), 
living with a rare disease (relations with others, everyday life, work, changes), 
being a man/being a woman, 
the presence of associations. 
The experience of caring for people living with a rare disease: 
describe a rare disease, 
the “patient” when they present at the center (the first meeting, expectations), 
relating to patients seeking a diagnosis, 
identifying the disease, 
the quest for a diagnosis (reporting it to the person), 
accompanying the treatment (offering support, being a point of reference, relating to the chronic aspect of 
the disease, dependence-independence, clinical deterioration, drugs), 
the relationship with the patient and with his/her family/caregiver (people involved with the patient, 
understanding each other, difficult aspects/facilitative aspects). 
 
The outlines were drawn up, starting with some models of disease history presented in the works by 
Giarelli (2005) and Wilcock, Brown, Bateson, Carver, and Machin (2003), and they were adapted to the 
context of the study. 
The interview outlines were then reviewed by a group of professional health care providers at the Regional 
Center for Rare Diseases and by some patients. They were used as guides for the interviews. A series of 
open questions were also provided which were based on the interview outlines. These questions could be 
used if it was necessary to encourage the interviewee to reflect on or share his or her thoughts. 
The interviews took place in a quiet, isolated room in the sole presence of the interviewer and the 
participant, and they were recorded. In one case, the interview with the patient took place in the presence 
of a family member. All of the interviews were conducted in Italian. 
Between May and September 2010, there was a pilot study with four interviews with patients and four with 
professional health care providers. This initial phase of work made it possible to fine-tune the outlines for 
the interviews, identifying some more specific open questions to stimulate considerations on some aspects 
that emerged as being significant. 
Data Analysis 
We adopted a phenomenological approach for this study. The aim of this research method is to describe 
the significance of the experience from the perspective of the individuals who have lived it to obtain 
greater knowledge of the nature and significance of that experience. The experience of the interviewees is 
the focal point of the phenomenological investigation as it is an element that is able to attribute meaning 
to the individual’s perceptions of a particular phenomenon (Speziale & Carpenter, 2011). 
The concepts of phenomenology essence, intuition, and reduction are the basis of the research method 
chosen. The essences are elements related to the ideal or real meaning of the phenomenon under study, in 
other words of those concepts that are able to identify a common knowledge of it (Fain, 2004; Speziale & 
Carpenter, 2011). Intuition represents the capacity of the researcher engaged in the description of the 
experiences to acquire an accurate and complete interpretation of it (Fain, 2004). Phenomenological 
reduction is a method of analysis that is able to guarantee an approach that is as free as possible from 
conceptual premises and the opportunity to describe the phenomena experienced as faithfully as possible. 
The reduction process fundamentally requires identifying any previous knowledge, idea, opinion, or belief 
regarding the phenomenon being studied. Once all this has been identified it is necessary to separate it 
from the object of the investigation, in other words to “bracket” it. This allows the researcher to have an 
impartial approach and makes it possible to collect accurately what emerges from the data under 
examination (Speziale & Carpenter, 2011). 
We analyzed the interviews using Colaizzi’s (1978) procedural interpretation as described by Polit and Beck 
(2013). Three different researchers analyzed the data separately and at the same time. 
They carefully and repeatedly read all of the interviews to acquire a feeling for them. Then they reviewed 
each interview and extracted significant statements. They spelt out the meaning of each significant 
statement and organized the formulated meanings into clusters of themes, and after that they referred 
these clusters back to the original protocols to validate them. At this point, the three researchers compared 
their analyses to highlight and discuss any discrepancies and to reach an agreement. Then they integrated 
the results to formulate an exhaustive description of the phenomenon under study. 
The quality of the study was ensured using the Lincoln and Guba framework (credibility, dependability, 
confirmability, transferability, and authenticity) as described by Polit and Beck (2013). Credibility and 
dependability were ensured through the use of an audit trail, verbatim transcription, and member 
checking. Where possible, the descriptions were returned to the participants for their confirmation. 
Results 
We conducted the interviews between May 2010 and January 2011. Each interview, which lasted between 
30 and 60 minutes, was recorded. The interviews with the patient participants and with the professional 
health care provider participants were analyzed separately. This was a deliberate choice so as to maintain 
the wealth of considerations that emerged, and as a result, the themes that arose were slightly different in 
the two groups. 
The analysis of the texts of the interviews led to the identification of nine themes (five for the patient 
participants and four for the professional health care provider participants) with essential elements (see 
Tables 2 and 3). We chose some excerpts from the interviews to illustrate each theme. They are useful for 
understanding the participants’ experience, but they are not exhaustive of the many nuances that 
emerged. To guarantee the anonymity of the participants, the phrases are reported anonymously, 
accompanied by a code. 
Results of the Interviews With the Patients 
Dealing With Disease Development 
Getting a diagnosis 
Various patients remember how difficult it was to get a diagnosis of their disease. Often the symptoms they 
felt were aspecific and therefore hard to place in the context of standard diagnosis procedures. This meant 
that they had to see several specialists and undergo various diagnostic tests: 
I used to go to the Molinette hospital but we rather neglected (the disease), then the thing continued . . . I 
did not think it was a disease . . . I mean serious. Then my daughter met a woman on the train and talking 
she told her about the G . . . and a woman doctor examined me . . . then I went to the Molinette for a 
capillaroscopy. Then they told us that here there is the Rare Diseases Centre and I came here, and that was 
it! It took rather a long time before they discovered the disease . . . (Patient Participant 3) 
For several patients, getting a diagnosis was experienced as a difficult process above all because they did 
not understand what was going on: 
Quite frankly I did not know what it could be . . . I was a bit, in limbo. If at first I experienced it as “They are 
trying to find out,” when they admitted me to hospital in nephrology I had the feeling “If I’m here I’m really 
ill!” (Patient Participant 10) 
Treatment approach 
With regard to the treatment, what emerges as fundamental—but not simple—is identifying the most 
effective drugs and finding the right balance in the dosage, taking into account the variability in the 
response of each individual patient. 
Patients often refer to the side effects which are difficult to manage and which have a high impact on 
everyday life. In addition, they stress the obligation of having to periodically undergo treatment in hospital: 
[In the period when the patient was taking 500 mg/die of cortisone] “I couldn’t sleep, I wasn’t sleepy, I was 
always frenetic. I couldn’t stay seated, I couldn’t even watch television. Sometimes I said to myself: ‘I don’t 
recognize myself!’ I irritated the others and it irritated me that the others would remain seated and still.” 
(Patient Participant 7) 
It’s twice a month, not so often; but it’s . . . I don’t like it. It’s . . . you know, it’s the idea, isn’t it? Also 
because it creates dependence, in the end, and you can’t escape it. And . . . let’s say, you feel that a little bit 
of freedom has been taken away from you. (Patient Participant 4) 
See progression between remission and relapse 
What characterizes the course of most of these pathologies is alternation between moments of stability 
when the symptoms of the disease are not evident and phases of relapse when the pathology reappears in 
an acute form and the patients feel the progression of the disease which they react to with anxiety and a 
sense of uncertainty about its possible evolution. 
During the phases of relative well-being, the disease is not evident, it becomes a disease that “you can’t 
see.” 
I think the problem is that quite rightly . . . for example, if a person has a broken arm you can see it! But we 
. . . our diseases—I speak for myself, but I have seen this with others too—no-one would think you had 
anything wrong with you. (Patient Participant 13) 
Predicting the future 
This aspect crops up in many of the interviews. There are three elements: uncertainty about the more or 
less rapid or aggressive evolution of the disease, the fear of its worsening, and the hope that the stability 
obtained can be preserved. 
Going forward . . . I am afraid of later, a little. I say to myself: “Perhaps now I am managing more. I am more 
. . . But later I say: I wonder how much longer it can hold out.” (Patient Participant 6) 
 
 
Living With the Disease 
Adaptation strategies 
Patients report that they adopt different adaptation strategies for coping with the disease. They consider it 
effective to try and have a positive or optimistic approach to the disease and the treatment, trying as far as 
possible to lead a “normal” life: 
The disease is part of us. Unfortunately we have to do all we can to resolve it with the support of the 
doctors, but it is basic . . . our reaction, our wanting to get better, never letting go. Thinking that there is 
always a way out. It may also be chronic, but it is a chronic that you can easily live with, because it is a very 
bearable chronic . . . once you can use your hands, be grateful. (Patient Participant 18) 
Being able to accept one’s condition of disease, learning to live with it, turns out to be the most appropriate 
way to improve one’s quality of life, even though sometimes it may be necessary to change some habits. 
What I am allowed to do. Every morning I get up really early to get an hour of time to do training: doing 
some everyday maintenance exercises, even though . . . my hands have deteriorated a lot. Above all I 
realize because in some exercises I cannot get up to the same speed that I used to. But it is also true that 
you can make up for it with the experience of expertise acquired over the years. (Patient Participant 21) 
Patients often describe the work they had to do with themselves to activate the resources that are 
essential for dealing with the condition of disease. To find the inner strength to go on, to get up after each 
fall, and sometimes to turn a condition of weakness into one of strength: 
At the beginning I was upset: I spent the days crying. Then in the end I looked at myself a moment and I 
said: “Yesterday I cried; and I did so the day before yesterday too, and also the other evening, and last 
month . . . the disease won’t go away. Indeed quite the contrary, I will just go and get worse at the cerebral 
level!” (Patient Participant 20). 
The quest for independence 
Many of those interviewed stress the need to maintain areas of autonomy in their work and in their 
everyday activities, even when the limitations imposed by the disease make this difficult. 
What often emerges is the patients’ difficulty in asking for and/or accepting help from the members of their 
family and friends or acquaintances. Patients experience this aspect as a potential loss of their 
independence and therefore as a defeat: 
I have not been to the market by myself for two years. I always go in the company of my husband. And that 
brings on a nervous breakdown because I was used to doing it alone. I am not . . . I shall have to get used to 
asking. (Patient Participant 16). 
The need to know the disease 
Often patients express their need to acquire information about their own disease independently. The most 
common means is looking up information on the Internet, but patients also use texts or take part in specific 
conferences on the subject: 
I did my research by myself on internet, I downloaded all kinds of things, I have got that much stuff; and 
then the psychologist told me: “Now that’s enough! Indeed you already know too much about your 
disease!” (Patient Participant 18). 
Everyday Living 
Functional limitation 
The limitations deriving from the condition of disease touch various aspects of everyday life: being able to 
move about autonomously and carrying out various activities of everyday life such as eating, sleeping, or 
managing holidays, free time, and recreation activities independently. Sometimes what is compromised is 
the chance to have an adequate social life. 
But as it is now I’m taking it badly, because I can’t do anything, I get palpitations, I . . . I have my 
grandchildren and I can’t hold them in my arms . . . And nobody says anything to you! (Patient Participant 
17) 
Experiencing pain 
The experience of pain is widespread among those interviewed while the ways pain comes on, it’s 
perceived intensity and reactions to it are subjective. Often the experience is all-absorbing, concentrating 
patients’ attention and limiting everyday activity: 
I can’t take it any longer: I did not even recognize my husband I was in so much pain; it was really 
unbelievable! (Patient Participant 19) 
Influence on work 
For some of those interviewed as the disease progressed, it became incompatible with maintaining a job. 
For others, the condition was limiting for the development of their career or it was the reason for 
unwanted job reallocation to not very gratifying positions. 
In practice this esophagitis, as I had to lift boxes, I used to bend down, which was very bad news! It was 
really something . . . And after a few years there was redundancy, and so my husband said: “Listen, as there 
is this redundancy, volunteer for it and you can stay at home.” I didn’t want to, I did not . . . And all in all, in 
the end I agreed to. (Patient Participant 2). 
Relating to Others 
The role of the family 
The role of support played by the family emerges frequently in patients’ narrations. The role of support by 
the partner, children, and other family members is fundamental in helping the person with the disease to 
accept their condition and tackle daily difficulties more serenely. 
Some patients express the fear that their need to be helped can be a burden for their families; others point 
out the changes that their state of illness has brought about in their relations with family members: 
Sometimes I don’t say everything because I don’t want to burden them further; but my daughter, apart 
from the fact that she is a psychologist, is in a class apart as regards her understanding at a glance! In other 
words she comes in, takes one look at me says: “Mum, you were in pain last night! You are walking a bit 
crooked . . . ” Yeah, she observes me! (Patient Participant 18) 
And then a thing that I miss is that . . . since I separated—and it is linked to my illness, because . . . .with all 
my problems I distanced myself a lot from my ex-husband . . . I would have liked to have a child, but when 
you find yourself in certain situations . . . It’s a big decision to make! (Patient Participant 14) 
Comparison with other patients 
The comparison with people with the same pathology is an element which crops up time and again in the 
narrations of those we interviewed. The patients observed themselves and sought their symptoms in other 
people. The comparison is sometimes deliberately sought, and at times it is avoided, as there is the fear of 
seeing possible negative developments. Often the patients in the waiting room will exchange their stories 
and experiences. This relationship may continue outside the treatment context (outside the surgery, clinic, 
or hospital). Patients often feel the need to contact associations that deal with patients with rare diseases. 
One day there was a woman, here: first we were on the drip at the same time, I didn’t know what she had; I 
saw that she couldn’t open a bottle. It just slipped out when I said: ‘You can’t open it, do you want me to do 
it?’ Then the nurse came along and she opened the bottle. Then she asked me what was wrong with me, 
and I dared to ask her: ‘What have you got? Why can’t you open it?’ And she told me that she had 
scleroderma, she must have been about 40 years old . . . This woman talked . . . she talked! Then we also 
met up outside the hospital. (Patient Participant 16) 
Relations With Professional Health Care Providers 
Admission and follow-up 
Most patients express considerable satisfaction about how they are taken care of by the staff at the health 
care Center, and in particular what emerges is the positive memory of the welcome they received during 
their first meeting. Some stress the positive aspect of finding the answer to their multiple problems in the 
team present in a single center. 
Then he said: “Listen, now if you agree I would admit you to be followed by our team!” Now I nearly burst 
into tears I was so happy! Because I said: “Look, I could ask for nothing more as I really don’t know what on 
earth to do at this point!” (Patient Participant 15) 
Some patients point out some critical points with regard to their admission. They have a negative view of 
the turnover of the doctors who are still specializing, as it makes them feel that there is discontinuity in 
their admission and follow-up. 
My only . . . criticism is that it doesn’t make sense for me to see . . . all the doctors leave. When they get to 
know you, they know about your problems and then you have to start all over again. Perhaps you have built 
up a certain degree of familiarity with the doctor and then you get another one. (Patient Participant 10) 
Features of the relationship 
In their interviews, the patient participants often refer to the skill shown by professional health care 
providers in establishing positive relations. Many appreciate the quality of the relationship established with 
them, with their empathy and humanity, and the patient participants stress this helpfulness. 
Now, I have to say this: I have found some marvelous people during the course of my illness . . . Because 
everyone has done all they could and everyone has tried in any case to help me; they have never given up. 
And I must say that I have been really lucky . . . . (Patient Participant 15) 
However in some interviews, a negative dimension arises about the patient–staff relationship which is to 
do with a “lack of attention,” to haste, to the insufficient resources: 
But I must be absolutely straight with you, I said: these people have not even taken the commitment 
seriously. . . They have just given me some pills that I buy. . . It’s not enough! Here the Doctor is always 
busy here and busy there, she never stays very long. (Patient Participant 6) 
The need to receive information 
In the complex and unusual diagnosis and treatment process, patients express their need to receive 
constant and understandable information. Some are able to express this need to the professional health 
care providers whereas others find it more difficult to do so. 
In the interviews, patient participants stress the professional health care providers’ ability to use language 
that is understandable and suited to the patient: 
Because it is true that patients are often annoying! Petulant, they always ask the same things. But once you 
have understood that that patient has that characteristic . . . it is necessary to give that patient suitable 
answers! (Patient Participant 12) 
Instead some patients reveal that their need to receive information is a critical issue. 
Maybe what’s missing, but I don’t know to what extent, is precisely to give more information about your 
illness . . . Also to know why. Because, well . . . perhaps they don’t know much more than we do. (Patient 
Participant 13) 
Taken as a whole, the means used so far to provide patients with information are in any case perceived as 
satisfactory. 
Results of the Interviews With the Professional Health Care Providers 
Dealing With the Disease 
The patient’s experience 
It emerges from the interviews that the professional health care providers are attentive to recognizing the 
difficulties patients have in dealing with a diagnostic procedure that is often long and tiring. They stress 
how the patients arrive at the center after an experience marked by multiple tests, doctors, experiences in 
various hospitals. When our professional health care providers meet these patients, they consider it 
important to take their history into account, to be delicate and patient, to devote time to them: 
There is no doubt that the fact of having a rare disease makes it even harder for people to find their way 
because in effect it is not easy to arrive at these diagnoses. (Professional Health Care Participant 1) 
The professional health care participants recognize in the patients an experience of pain, suffering, linked 
also to the difficulty of managing everyday life because of their symptoms or invalidating conditions which 
have a strong impact on their personal choices: 
Already just the fact of working or resting. If I still have a job, with the crisis that there is in the job market, 
these people have to take days off, also several times a week to do their treatment, perhaps they have 
every right to do so but sometimes they say: “I went to work even though I did not feel at all well so as not 
to lose my job.” (Professional Health Care Participant 3) 
Rare diseases are a set of conditions that bring patients together but which also at the same time 
profoundly mark those who have them. The same rare disease may bring together some very different 
experiences. In their interviews, the professional health care provider participants often refer to the 
multiple types of participants who come to the Center and to the different means of interpreting the 
disease as regards the various expectations, experiences, and requirements: 
I have two patients P. and A., one is nearly thirty, the other is about thirty, and they have the same disease 
but they experience it in a different way. One distances herself from the illness, sometimes she comes, 
sometimes she doesn’t . . . the other tries to find other approaches, other drugs, looking also outside Italy. 
(Professional Health Care Participant 4) 
The specific nature of rare diseases 
Some interviewees point out how difficult it is to speak of rare disease because it is a general term, based 
on an epidemiological criterion, which covers very different pathologies, each one with broad spectrums of 
possible disease expression. In some interviews, there is an attempt to identify some specificities in the 
experiences of patients with rare diseases which sets them apart from other types of patients: 
The problem of rarity is a problem of a certain weight: the problem is that the pharmaceutical companies 
do not make drugs, i.e. orphan drugs, for them; there is the fact that doctors do not know the disease, even 
though in reality it is often not like that because many rare diseases are less unknown than what people 
say, but instead some really are; and there is the fact that they cannot find other patients and so there is 
the sense of solitude that patients often find themselves experiencing. (Professional Health Care Participant 
5) 
The chronic nature of the disease 
The professional health care participants describe the chronic and degenerative course of these pathologies 
and their seesaw progress with periods of remission alternating with periods of relapse and so constant 
checks are required together with long-term treatment. In particular, the professional health care provider 
participants stress how, as it is impossible to cure these diseases, it is important to keep them constantly 
under control, to prevent or to intervene swiftly on possible worsening: 
You have to be a sort of bloodhound with the patient, I don’t know how to explain it. You must never let 
him go. Maybe he will tell you he is well, or he reports something to you that may not mean anything. But it 
could be a complication, the beginning of a serious problem. If you overlook it, the prognosis could get 
worse . . . (Professional Health Care Participant 12) 
In these moments, the professional health care participants themselves can feel discouraged, sorry for the 
patient, and, in some cases, defeated because they have not been able to prevent the worsening of the 
disease. 
Treatment management 
The interviews reveal the complexity of the treatment choices and management. Many of those 
interviewed explain how it can be difficult to swiftly identify the best treatment approach: Often there are 
few studies to refer to and there is a subjective variation in the response to a drug. 
For us it is probably easier to find a treatment for a patient who has a common illness because it can be 
studied better, rather than to give one to a patient who has a disease that only another ten people in the 
world have. There are no studies; we are blundering about in the dark . . . (Professional Health Care 
Participant 11) 
Often it may be necessary to vary the treatment in time. Often the choices have to be negotiated with the 
patient. 
Dealing With Expectations 
Admission and follow-up 
The professional health care participants interviewed report how it can be difficult to find someone to 
follow these patients, be it a specialist or an appropriate center. This may be because patients seek 
someone who can take them on globally, with a holistic approach which is not exclusively linked to 
individual problems: 
Usually patients with a rare disease arrive in our Center after a long period through other centers and with 
other doctors; they already have an experience of disease, tests, suffering. They arrive here with a lot of 
expectations. (Professional Health Care Participant 6) 
Being of assistance 
According to the professional health care participants, patients have great expectations from the 
professional health care providers of the rare diseases Center: They hope to find a stable reference for their 
problems, they expect a clear and conclusive diagnosis, they hope to receive suitable treatment and to be 
followed in the progression of their disease: 
They want a lot of confirmation from the doctors about the treatment, the tests. But I find that they are 
followed in an exceptional way. There is a lot of attention to the patient, he is not lost. Even a patient who 
does not show up for a while is called to find out how he is doing. There is a lot of attention, I repeat, and I 
have never seen that in other places. (Professional Health Care Participant 3) 
Inadequacy and frustration 
The interviews reveal how difficult it is to live up to the patient participants’ expectations. The diagnosis is 
not always reached in a short time or it may not be possible to reach one at all, and the treatment is not 
always effective or does not guarantee the result desired by the patient: 
Above all they want a diagnosis. Sometimes we are able to find our way in the field of pathology, 
understand for example that this pathology is autoimmune, that it is necessary to prescribe an 
immunosuppressive treatment . . . for a certain period we say that it is necessary to ‘freeze’ the diagnosis in 
a certain sense, not to give it a name immediately. (Professional Health Care Participant 10) 
The professional health care provider participants consider the subject of recovery to be particularly 
delicate. They know that some patients do have this hope and that it is highly unlikely to happen as these 
are chronic pathologies. 
Being unable to meet patients’ expectations can sometimes entail an experience of frustration and 
disappointment both in the patient and in the professional health care provider. 
We aren’t always able to give a diagnosis. . . . These patients remain a bit not so much discouraged as 
disappointed. They come to us and they expect that there is a cure for this disease and instead there isn’t 
one, because it has not yet been discovered or because it does not exist! (Professional Health Care 
Participant 7) 
Sometimes the expectations of these patients turn into expectations toward the professional health care 
staff and the Public Health System, from which a great deal is expected in terms of attention and services: 
Some live with the impression that the rare disease is something different from other diseases, when this is 
not the case. Some think: “If I have this disease everyone owes me: I must look after myself, you must look 
after me and you must give me these drugs free.” (Professional Health Care Participant 12) 
Building Relationships 
Features of the relationship 
The patients who come to the Center are followed for very long periods. They can even have several 
appointments per month for treatment and check-ups. This continuity of relationship facilitates lasting 
relations. Some professional health care participants describe the relationships that can become 
established between themselves and the patients very positively thanks to the trust and sometimes 
friendship that is created. They point out how this aspect can have a positive influence on the management 
of the patient himself: 
I really see that sometimes for the patients, above all those with rare diseases, it is necessary to have some 
words of comfort . . . If this human aspect is missing I notice that the patients have more difficulty, even in 
understanding the treatment, and understanding, for example, why there is no drug available. (Professional 
Health Care Participant 9) 
Some stress how there is a certain variability in the relations, depending on the character of the person or 
of the professional health care provider and in the way both of them deal with and conceive the disease. 
This can make empathetic interaction and mutual understanding difficult. 
Sometimes a situation of mutual dependence is created, with the risk that the doctor cannot always 
maintain the necessary lucidity to deal with situations and for the patient to feel lost when he is entrusted 
to another doctor: 
Instead often the patient becomes dependent on the doctor. We see this here where in any case we are a 
university Centre, so the doctors who follow the patients directly, who are the doctors doing their 
specialization period, change each time. The patient feels lost. (Professional Health Care Participant 5) 
Some professional health care participants point out the risk that they may end up by being too involved, 
for example, by allowing the patient to contact them at home, becoming a point of reference also for 
problems that are not directly inherent to the rare disease, and they suffer detachment strongly. 
 . . . Worried because then among other things I do not know whether I made a mistake or not; I gave a 
number . . . my mobile number, my personal one. So nearly every Saturday or Sunday I was called . . . That 
anyway always . . . always in touch, for whatever reason! (Professional Health Care Provider Participant 12) 
Relationship with informed patients 
Many professional health care participants stress the difficulties encountered with working with patients 
who are often very well informed about their pathology. They explain how these patients gather a vast 
amount of information on the Internet, but that they do not always have the competence to analyze this 
information in a critical way. This situation can give rise to some problems because of the heterogeneity of 
the sources and because of an approach to the disease which is at times different from that of evidence-
based Western medicine. It can become difficult to establish relationships of trust with informed patients 
because the medical staff are assessed on what they say about the disease and its treatment. Often 
professional health care participants explain how important it is to be perceived as honest and sincere, and 
to propose to the patients that they should discuss together the information gathered: 
Sometimes the information becomes misleading, above all the info found without suitable instruments, on 
internet, “googling” the name of the disease . . . decoding that mass of information that the patient has 
found on internet and seeing whether he has really understood what is accepted in the scientific 
community . . . Sometimes I say that he should print it for me and we can talk about it together. 
(Professional Health Care Participant 8) 
Family involvement 
The interviews reveal how the professional health care provider participants recognize the important role 
that the family plays for their patients, providing a fundamental support both for the emotional aspects and 
in the management of everyday living. 
Family members often accompany the patient for the check-up or treatment sessions and ask to sit with 
them, to be informed on how the treatment and the disease are progressing. The professional health care 
provider participants consider it important to involve them while always respecting the limits of privacy. 
The family is considered a good resource: They know the disease of their family member very well and 
often they are the first to notice any changes, signals of possible worsening, and to tell the doctor: 
The patient’s family notice changes. Take a patient who is well and who then at a certain point does not 
want to go out any more, and sleeps all the time, then maybe the wife will call me to tell me that there’s 
something wrong. I think the patient’s family are little experts on the disease . . . (Professional Health Care 
Participant 6) 
However, some professional health care provider participants point out how sometimes it is difficult to 
relate with the family because they display a level of anxiety and worry about the condition of the patient’s 
disease that is often worse than that of the patient himself: 
Often the family asks more questions than the patient himself, perhaps the patient is a bit disorientated, 
only attentive to his symptoms . . . he talks about what he experiences. Instead the family wants to know all 
about the impact this can have! In other words, whether this disease can be hereditary; above all if they 
have any children, if it can be transmitted, whether anyone in the family might already have it or not . . . 
they want to be reassured too. (Professional Health Care Participant 11) 
Being Operators in the Context 
Relations with other professional health care providers 
The interviews reveal how the CMID is a Center where various professionals are at the disposal of the 
patient to take care of him. In general, the professional health care provider participants report a serene 
work environment and good relations among all the professional staff. They point out how mutual 
willingness to help, cooperation, and the opportunity to compare notes are positive aspects: 
If there is a person who can’t give you an answer on the spot you can soon have a chance to check with 
them. Colleagues are very helpful, also staff at different professional levels, willing to talk to each other, to 
tell each other about issues concerning the patients. It’s positive, you don’t feel alone or at the mercy of 
situations that you don’t know how to deal with in that moment. (Professional Health Care Participant 1) 
In particular, what emerges as being important for the medical team is the multidisciplinary aspect. The 
presence of doctors at the Center with different specializations makes it possible to tackle the various 
multi-organ problems that rare and chronic diseases can entail. The professional health care participants 
stress the usefulness of being able to discuss cases together so as to better investigate the situation of a 
patient and they explain how this is a service also for the patients who can thus consult with specialists 
directly without having to go to another Center: 
As this is a multidisciplinary Centre, with many specialists, we can observe the patient from various 
viewpoints: this enables us to understand the patient and his disease better. For the patient I think it is a 
positive aspect too because it means he is not passed around like a parcel between various doctors, he 
trusts us and so he entrusts himself to us . . . (Professional Health Care Participant 1) 
On the other hand, some professional health care provider participants stress how integrating the various 
specialists is not so easy: One may be missing who would be the point of connection between the various 
points of view. 
The nursing staff instead express the need for greater involvement within the medical team as regards the 
diagnostic, treatment, and support process: 
Being involved . . . today we talk about this patient, what his prospects are, programmes, not only from the 
point of view of the treatment but also the general picture of the patient. I know this has been done, 
between the doctors and ourselves we have been a bit left out. This is not a criticism, it is just that I would 
like to be involved a little bit more in the general picture of the patients. (Professional Health Care 
Participant 3) 
Managing difficulties 
The interviews reveal that there are some aspects that the professional health care provider participants 
consider to be critical in the organization of the CMID. They feel the need to have greater spaces for 
receiving patients, both to guarantee greater privacy and intimacy during interviews, and so as to better 
manage the moments devoted to infusion therapy in the day hospital: 
In a room that is half the size of this one, we have from fifteen to seventeen patients do treat in the eight 
hours of the day, concentrated all together, and at times you cannot follow them all well. (Professional 
Health Care Participant 4) 
Some professional health care provider participants express regret about the long waiting times that 
patients have to undergo. They think that these can be disturbing for patients who already have a history of 
fatigue and anxiety about their uncertain condition. Others fear that an increase in the number of patients 
can make the difficulties acute. They consider that it would be useful to better define the indications and 
appropriateness for access to the Center and admission of the patients followed there. 
 
 
The nature of the role 
In their interviews, the professional health care provider participants refer to the various activities that are 
carried out at the CMID and which can give rise to a certain degree of confusion not only in the patients but 
also in the external professional health care providers who use it such as the family doctors. At the CMID, 
three different activities are carried out: bureaucratic work, research, and health care. As regards the 
bureaucratic side, the Center does administrative work which regards aspects of exemption from payment 
for treatment and the management of the Register of Rare Diseases. This bureaucratic function means that 
there are often conflictual aspects between professional health care providers and users who pursue 
different objectives or who view the Center in different terms, expecting different types of health care: 
I have had to do with another aspect of the CMID, the aspect of . . . Center of Coordination of Rare Diseases 
of the Piedmont Region. This means an activity which is bureaucratic from a certain point of view because it 
involves inserting these patients in the Regional Register; issuing exemptions and after that a treatment 
plan if there is one; this means exemption from the ticket (according to the Italian National Health system, 
those without a ticket exemption have to co-pay for their treatment up to a certain minimum sum—called 
“ticket”—after which treatment is dispensed free of further charge) for the tests that need to be done and 
the treatment plan with free drugs . . . And so for many this is something . . . important; for some 
sometimes perhaps it is more important than the concept of undergoing treatment. (Professional Health 
Care Participant 12) 
As regards the research aspect, nearly all the professional health care provider participants consider this to 
be at a very high level. The Center is considered a dynamic and innovative study context, an environment 
able to provide great opportunities and to provide enriching skills, providing opportunities to broaden 
knowledge. 
The moment the issue moves from the research dimension to that of health care, the professional health 
care provider participants reveal a sort of ambivalence, in particular as regards experimental treatments, 
between the positive opportunities for research and the critical aspects regarding the administration of 
experimental treatments, the unpredictability of the risks and consequences; they are well aware that 
improvement is not guaranteed, nor is it sometimes even possible to assess. 
The risk is the unsatisfactory efficacy of a drug which produces a sense of frustration in the professional 
health care provider participants, particularly when they are faced with deterioration in the patients: 
As ours is a centre of documentation on rare diseases, they come to you hoping that you can give them the 
most suitable treatment that can help them to get better. Instead you have to point out that unfortunately, 
as these are rare diseases, firstly there are not always codified treatments, and secondly that unfortunately 
the disease, though it can be kept under control, will not get better. (Professional Health Care Participant 6) 
Discussion 
People with rare diseases report an experience of suffering, anxiety, and fatigue linked to the phase of 
onset of the disease. This is caused both by the symptoms, which can be severe, and by the difficult and 
often long process of finding a diagnosis with many tests, specialist consultations, admission to various 
hospital wards and institutions. Often patients experience a sense of isolation and disorientation. In 
literature, it emerges that patients with rare diseases experience delay in identifying a diagnosis as being 
one of the greatest problems (Faurisson & Kole, 2009). Providing a diagnosis, a doctor might give meaning 
to the personal sensations of a patients, legitimizing their illness experience (Corbin, 2003). 
After diagnosis, and finding a Center where they can be followed, the attention of the patients participants 
shifts to how to manage the disease on an everyday basis. The condition of their disease being rare is not 
described or referred to as the most problematic element. A French study has pointed out how these 
patients do not perceive the aspect of rarity as the greatest source of difficulty, so long as they have found 
health professionals who are able to recognize their requirements (Huyard, 2009). 
The patient participants focus their attention above all on the difficulty of living with symptoms that impact 
on their daily lives, which can cause limitations or changes in their habits. They also stress the problem of 
their need for long-term therapy, some of which has serious side effects, and the need to frequently go for 
check-ups and tests which takes time away from their personal lives. 
The problems that emerged, rather than indicating the specific nature of rare diseases, are similar to those 
of many people who have chronic and degenerative diseases with whom those interviewed share also the 
problems of a social nature, such as the difficulty of holding down a job, the need to move near the health 
care Center, the choice made by some family members to devote themselves entirely to looking after the 
patient, abandoning their job (Faurisson & Kole, 2009). 
Living with a chronic, degenerative disease requires a complex process of adaptation to a changeable 
condition that upsets the order with which a person’s existence and perception of self was organized 
(Kralik, 2002). Many of the patient participants interviewed talk about how they have developed adapting 
strategies to deal with their new condition of life. They report that these are effective for living with their 
disease. Despite the presence of chronic and often degenerative diseases, the objective of maintaining a 
life that is as normal as possible is defended as a value and it is experienced as possible by patients 
(Joachim & Acorn, 2003). It is the everyday experience, made up of trial and error, that makes patients able 
to manage themselves in their disease (Kralik, Koch, Price, & Howard, 2004). 
Patients conduct a process of re-elaboration to bring the presence of the disease in their lives from an 
extraordinary event to an ordinary event that they can live with (Kralik, 2002). This is a continuous and not 
linear process with phases of adaptation and phases of re-negotiating the patient’s condition, also as a 
result of the progression of illnesses that often alternate phases of clinical stability with phases of 
worsening. 
Within the patient’s process of the reconstruction of his/her identity and adaptation to the illness, the 
encounter with the health service world plays a decisive role. According to what the patients have 
reported, their arrival at the CMID meant finding a stable point of reference in the course of their disease. 
The patient participants showed that they did not only seek a place where they could receive care and 
treatment but also a place where they could be welcomed, understood, and involved. For them, it is 
necessary to build a treatment alliance with the health care staff to deal with the process of adaptation to a 
life that is altered by the arrival of the disease. What is said and exchanged during the meetings between 
the patients and the health care staff can influence in a positive or negative way the patient participant’s 
efforts to reconstruct his/her self-image (Telford, Kralik, & Koch, 2006). 
The professional health care participants have shown themselves to be particularly sensitive toward the 
patients’ experiences of discomfort and their difficulties. They recognize the suffering caused by the impact 
of the disease and stress the need to treat patients with helpfulness and delicacy when they come to the 
Center for Rare Diseases. The staff explain how relationships can develop which are intense, lasting, 
sometimes relationships of friendship. Following their patients for a long time, they feel they participate in 
their histories, at times becoming points of reference for the patients even for problems which are not 
strictly to do with the disease. The risk is a strong emotional and workload for the health care staff and an 
excessive involvement which can at times make it hard to maintain lucidity in treatment choices or can 
make detachment from these patients painful when this occurs. 
Often professional health care participants show that they do not have a uniform approach toward 
patients. In some moments, they seem to place the person at the center of their professional actions, 
letting an empathetic attitude of attention to the experience of the patient prevail. At others, instead what 
seems to be paramount is attention to the disease and its treatment, where the specialist contribution is 
what counts, with the human component in second place. In any case, all the staff stress how building a 
relationship of trust with the patients can be a strong point in the course of treatment, guaranteeing better 
compliance by the patient with the treatment proposed. 
According to the professional health care participants, the admission of a patient who comes to the CMID is 
a delicate moment. They feel very strongly the burden of the patient’s expectations in terms of receiving a 
diagnosis, effective treatment in a short time, and prospects for the future. Patients often have absolute 
faith in medical science’s ability to solve any kind of problem, and when this does not happen, as one Italian 
study has suggested, this easily unleashes reactions of a lack of confidence in a health system that is 
considered not to be up to the job (Cipolletta & Oprandi, 2014). Moreover, the impossibility of responding 
to such high expectations generates a sense of frustration both in the health care staff and in the patients. 
One complex aspect that has emerged in the interaction between health care participants and patient 
participants, which is fundamental in building an effective treatment strategy, is that patients are 
increasingly well informed. Patient participants involved in the study report that they seek information that 
can help them to understand the progression of the disease and the treatment possibilities. Sometimes this 
quest is carried out in a way that is independent from the health care staff, via Internet, reading texts, and 
going to conferences on the subject. The information gathered is then measured against what the health 
care staff provides. 
The possibility of developing knowledge of their disease helps patients to continue to exercise direct 
control over their lives and over treatment. They can exercise a greater power in the interaction with the 
medical staff (Åsbring & Närvänen, 2004). However, the information patients find independently is not 
always understood, and if it is not accompanied by explanations, it can be disorientating. In literature, it is 
reported how often patients would like a guide to interpret the information they collect, expecting to 
receive explanations that they can understand (Huyard, 2009) 
The professional health care participants show as patient can have access to a mass of information which 
he is not able to select and it can lead to creating false expectations. They report how their approach is to 
propose that they can act as mediators, inviting the patient to discuss with them what they have found so 
that they can understand it better. If, at times, discussion with informed patients can test the doctor’s 
decision-making autonomy, today this is already recognized as an element that facilitates communication 
and the building of a relationship of collaboration with the health care staff (Aymé, Kole, & Groft, 2008). 
One aspect that has been identified as being complex regards the management of treatment for these 
diseases. The doctors explain how it can be difficult to swiftly identify the best treatment approach, as it is 
not evident in literature or because of the variability in individual response. This is not always understood 
by patients who want to obtain improvements rapidly. Moreover, doctors also report how—in a period of 
clinical stability—there may be negotiation with the patient about the quantity of drugs to take. Having to 
deal with patients who are often experts on their disease, or in any case people who know very well their 
individual response to drugs taken over a long period, at times leads the medical staff to discuss their 
treatment choices, and produce clear arguments or to give in to some requests. Doctors find that they have 
to take decisions together: with the patient they achieve a dynamic process, in which both parties make an 
effort to understand the needs and wishes of the other, in the context of a relationship of trust and respect 
(Lown, Clark, & Hanson, 2009). 
We realized the study in a Regional Center of Reference for Rare Diseases part of a clinical and 
epidemiological network. According to our patients participants, their arrival at this Center meant finding a 
stable point of reference in the course of their disease. For some this coincided with getting a diagnosis, for 
others it was a treatment process, for many this had the added advantage of ease of access to medical 
staff, check-ups, tests, and treatment in a single place, thus saving time and energy. For most patients the 
positive experiences regarded being able to establish a treatment relationship with the health care staff 
who are considered reliable and qualified. We suggest that patients want to find a Center that will admit 
them and follow them up in a holistic way, managing all aspects of their treatment. According to a German 
study, the associations of patients with rare diseases consider that the care of these patients should be 
based precisely on a holistic, multidisciplinary approach centered on the patient (Reimann, Bend, & 
Dembski, 2007). Increasingly, patients with chronic disease express the need to feel welcomed, 
understood, and involved in the treatment as they have to have a constant relationship with the various 
services. The perception of the quality of the care received often depends on the degree of involvement 
the patients have experienced in the system (Staniszewska & Henderson, 2005). 
Conclusion 
We wanted to explore the illness histories of patients and the experiences of the professionals who follow 
them, compare their portrayals and evaluate the strong and weak points of the course of treatment, 
creating the conditions for introducing elements of change that are considered useful for improving the 
course of treatment. 
From the results of the study it may be seen how, according to the experiences of the professional health 
care participants, the problem of disease rarity coincides with the difficulties expressed by the patients in 
reaching a diagnosis and in finding someone to follow them. Every day the professional staff find 
themselves up against the suffering caused by the impact of the disease on the lives of the patients and this 
also involves them emotionally, giving rise to feelings of impotence, frustration, and discouragement. The 
professional health care participants recognize as a further element of complexity in the relationship the 
fact that many patients are expert and aware of their own diseases and that this often imposes that the 
treatment choices have to be revised and more in general the means of interaction with the patient have to 
be orientated toward discussing the decisions of the clinical course of the health care. Every professional 
who works in this environment has to concentrate all the time on understanding also the patient’s 
unexpressed needs. Attention to the reaction of each individual patient, rather than proposing 
standardized solutions that cannot always suit everyone, can make it possible to fully understand the needs 
of each patient and to provide personalized strategies to satisfy those needs. The professional health care 
participants point out that a strong point of their work is the multidisciplinary approach that is adopted, 
which involves different specialists in a climate of cooperation and helpfulness in seeking the best 
treatment options possible (Kodra et al., 2007). 
The patient participants had to deal with numerous difficulties in their disease history. They experience as a 
significant moment the time when they found a point of reference for their treatment: A single place where 
they could be followed for medical advice, treatment, tests and check-ups, where they could feel welcomed 
and recognized. 
The subject of the rarity of a disease, once there has been a diagnosis and a treatment center has been 
identified, is not considered the most problematic element by the patients and by the health professionals. 
We conducted the study in a single Center of reference for rare diseases in a region of North Italy. The 
patients involved, followed as outpatients, were self-sufficient and with autoimmune type pathologies. The 
experiences and considerations that have emerged can therefore only be partially extended to other 
contexts. Moreover, the pathologies of the patients interviewed are different, and even though they have 
some common characteristics (chronicity, potentially invalidating, frequent treatment, and repeated tests), 
they make the experiences of the participants only partially applicable to other Centers. 
We provided the opportunity to promote attention on the subject of rare diseases. To understand the 
needs and difficulties encountered by people with these pathologies, together with the experiences of the 
health care staff who take care of them, has made it possible to identify areas that may be useful for 
improving the quality of the health care services. 
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Table 1. Characteristic of the Sample. 
 
Note. CMID, Multidisciplinary Center of Immunopathology and Documentation of Rare Diseases. 
 
 
 
Table 2. Themes and Essential Elements That Emerged From Patient Participants’ Interviews. 
 
 
Table 3. Themes and Essential Elements That Emerged From Professional Health Care Professional 
Participants’ Interviews. 
 
